Current and historical daily PE Ratio for Ipca Laboratories Ltd (
BOM:524494
) from 1994 to Jun 09 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Ipca Laboratories stock (BOM:524494) PE ratio as of Jun 09 2024 is 45.93.
More Details
Ipca Laboratories Ltd (BOM:524494) PE Ratio (TTM) Chart
Ipca Laboratories Ltd (BOM:524494) PE Ratio (TTM) Historical Data
View and export this data going back to 1994. Start your Free Trial
Total 1265
- 1
- 2
- 3
- 4
- 5
- 6
- 15
| Ipca Laboratories PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-10 | 45.3 | 2024-04-01 | 48.0 |
| 2024-06-07 | 45.3 | 2024-03-28 | 48.0 |
| 2024-06-06 | 45.0 | 2024-03-27 | 53.9 |
| 2024-06-05 | 45.5 | 2024-03-26 | 54.0 |
| 2024-06-04 | 44.2 | 2024-03-22 | 53.8 |
| 2024-06-03 | 43.6 | 2024-03-21 | 52.7 |
| 2024-05-31 | 44.6 | 2024-03-20 | 52.2 |
| 2024-05-29 | 50.1 | 2024-03-19 | 51.3 |
| 2024-05-28 | 51.1 | 2024-03-18 | 52.4 |
| 2024-05-27 | 50.2 | 2024-03-14 | 53.2 |
| 2024-05-24 | 50.3 | 2024-03-13 | 50.9 |
| 2024-05-23 | 50.7 | 2024-03-12 | 52.9 |
| 2024-05-22 | 51.1 | 2024-03-11 | 53.5 |
| 2024-05-21 | 50.6 | 2024-03-07 | 53.3 |
| 2024-05-17 | 50.5 | 2024-03-06 | 53.9 |
| 2024-05-16 | 49.7 | 2024-03-05 | 53.4 |
| 2024-05-15 | 49.4 | 2024-03-04 | 54.0 |
| 2024-05-14 | 49.9 | 2024-03-01 | 53.6 |
| 2024-05-13 | 50.3 | 2024-02-29 | 53.6 |
| 2024-05-10 | 50.9 | 2024-02-28 | 53.4 |
| 2024-05-09 | 49.7 | 2024-02-27 | 53.7 |
| 2024-05-08 | 51.0 | 2024-02-26 | 54.6 |
| 2024-05-07 | 50.1 | 2024-02-23 | 54.6 |
| 2024-05-06 | 51.8 | 2024-02-22 | 55.3 |
| 2024-05-03 | 51.8 | 2024-02-21 | 54.8 |
| 2024-05-02 | 52.3 | 2024-02-20 | 55.5 |
| 2024-04-30 | 51.9 | 2024-02-19 | 55.1 |
| 2024-04-29 | 51.6 | 2024-02-16 | 55.8 |
| 2024-04-26 | 51.8 | 2024-02-15 | 51.7 |
| 2024-04-25 | 51.4 | 2024-02-14 | 51.9 |
| 2024-04-24 | 52.2 | 2024-02-13 | 52.1 |
| 2024-04-23 | 51.3 | 2024-02-12 | 52.5 |
| 2024-04-22 | 51.5 | 2024-02-09 | 53.7 |
| 2024-04-19 | 51.8 | 2024-02-08 | 54.6 |
| 2024-04-18 | 52.4 | 2024-02-07 | 55.1 |
| 2024-04-16 | 52.0 | 2024-02-06 | 53.9 |
| 2024-04-15 | 51.4 | 2024-02-05 | 51.0 |
| 2024-04-12 | 51.9 | 2024-02-02 | 49.8 |
| 2024-04-10 | 51.5 | 2024-02-01 | 50.1 |
| 2024-04-09 | 51.2 | 2024-01-31 | 50.3 |
| 2024-04-08 | 50.1 | 2024-01-30 | 49.6 |
| 2024-04-05 | 50.9 | 2024-01-29 | 50.9 |
| 2024-04-04 | 49.4 | 2024-01-25 | 50.1 |
| 2024-04-03 | 47.4 | 2024-01-24 | 49.5 |
| 2024-04-02 | 47.7 | 2024-01-23 | 48.5 |
Ipca Laboratories Ltd (BOM:524494) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Ipca Laboratories Ltd
ISIN : INE571A01038
Compare
Compare
Traded in other countries / regions
IPCALAB.India IPO Date
1994-05-06Description
Ipca Laboratories Ltd is a specialty and generic drug manufacturing company. The company's principal activity is Development, Manufacturing and Marketing of Pharmaceuticals Products. The company operates multiple subsidiaries with revenue generation split roughly between India and the rest of the world. Ipca's products are exported to more than 100 countries across the globe. Ipca has only one reportable primary business segment, pharmaceuticals.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers